相关实验视频

Updated: Sep 12, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

乳腺癌激素治疗调节乳房植入物囊收缩收缩

Mehak Chawla¹, Gabriel Mirhaidari^2,3, Kevin Blum^1,2,4

¹From the College of Medicine, The Ohio State University, Columbus, OH.

Plastic and reconstructive surgery. Global open

|August 6, 2025

概括

在接受植入物重建的乳腺癌患者中,他莫西芬治疗显著降低了囊收缩率. 这种激素治疗可能是预防植入物并发症和减少修复手术的可行选择.

科学领域:

在瘤学瘤学.
整形外科整形外科整形外科
生物材料科学生物材料科学

背景情况:

囊收缩是植入式乳房重建后的常见并发症,通常需要修复手术.
临床前研究表明,激素治疗,特别是他莫西芬,可能会抑制植入物周围的囊形成.
这项研究调查了塔莫西芬在进行重建的乳腺癌患者中降低囊收缩率的疗效.

研究的目的:

为了评估他莫西芬治疗对乳腺癌患者囊收缩发生率的影响,这些患者接受了基于植入物的乳腺重建.
在这个患者群体中识别与囊收缩相关的风险因素.

主要方法:

一项回顾性病例控制研究分析了331名在2013年2月至2021年12月期间接受囊切除/囊切除的患者.
收集的数据包括人口统计,癌症治疗和手术细节.
使用单变量和多变量后勤回归模型来比较囊收缩率.

主要成果:

在植入时接受他莫西芬的患者显示,囊收缩的可能性降低了40% (OR 0.40,P=0.006).
放射治疗 (OR3.05,P=0.002) 和手术并发症,如血瘤/感染 (OR2.66,P=0.04) 增加了囊收缩的几率.
植入物特征,如胸下部位或非细胞皮肤基质的使用,并没有显著影响收缩率.

结论:

在接受植入物重建的乳腺癌患者中,他莫西芬治疗与囊收缩率的降低有关.
这些发现支持临床前数据,并表明局部激素治疗在预防植入物相关并发症方面可能发挥作用.
塔莫西芬可能是一个有价值的治疗策略,以减轻囊收缩和改善乳房重建的结果.

更多相关视频

Studying Normal Tissue Radiation Effects using Extracellular Matrix Hydrogels

Studying Normal Tissue Radiation Effects using Extracellular Matrix Hydrogels

Published on: July 24, 2019

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...